CSL employees sit on a balcony in Melbourne, Australia

In-Licensing for Australia and New Zealand

^{Pictured: CSL employees in Melbourne, Australia}

CSL Seqirus In-Licensing

CSL Seqirus has extensive experience in commercializing differentiated vaccines and treatments to help meet patient needs in Australia and New Zealand. This includes pediatric and adult vaccines, and innovative pharmaceuticals for patients living with allergies, cardiovascular disease, dry eye disease, severe pain, and neurological conditions.

Partnering Flexibility

We offer a flexible partnering approach, with an ability to tailor licensing arrangements to meet the needs of our partners. We have a proven track record across a range of therapeutic areas and channels, including GP, specialist and hospital.

Performance Driven Teams

Our multi-award-winning sales and marketing teams are recognized as leaders within the pharmaceutical industry. With expertise in both private and reimbursed products, we can help you achieve your commercial goals.

_{Pictured: CSL Seqirus employees in Summit, NJ, USA}

Strategic Market Entry

CSL Seqirus has dedicated regulatory and health economics team to secure optimum labelling and pricing in Australia and New Zealand markets.

We Make it Our Own

We make a significant investment and focus our resources during all phases of your product’s lifecycle.